This finding is in accordance with a study by Cho and colleagues that elegantly demonstrates that fibronectin type III domain is able to induce resistance to apoptosis in human lung cancer cells, through the activation of the PI3K-Akt/αvβ5 signaling axis53. Here, FN1 is linked to lung carcinoma.